for Research on Cancer has classified this bacterium as a definite carcinogen 2 . While the majority of the H. pylori infected individuals develop no significant clinical disease, some develop two kinds of divergent clinical diseases, PUD and GC 3 . The reasons for this may be related to differences in genetic susceptibility of the host, environmental factors, and genetic diversity of H. pylori 4 . In this context, the relevance of specific H. pylori virulence associated genes has been extensively studied. The cytotoxin associated gene A (cagA) was the first to be identified; about 60-70 per cent of H. pylori strains in the West were found to be cagA+ and these strains were associated with duodenal ulcer (DU) and GC 5, 6 . However, more than 90 per cent of H. pylori strains in Asia are cagA+ irrespective of DU and GC 7, 8 . The cagA gene can be classified into type A, B, C and D based on its 3′-terminal repetitive sequences 8 , however, the association of these subtypes with clinical disease remains unclear. The vacuolating toxin (vacA) was subsequently discovered and its allelic variants were identified in the signal region (s1a, s1b, s1c or s2) and mid region (m1 or m2) 9 . Specifically, vacA s1/m1 strains have higher cytotoxic activity than s1/ m2 strains, whereas s2/m2 strains have no cytotoxic activity 9 . Specific vacA genotypes are associated with level of toxin production and clinical diseases like PUD and GC in different part of the world [9] [10] . Studies have also provided evidence that bacterial adherence factors may also contribute to the pathogenicity of H. pylori. The blood group antigen binding adhesin (babA) has been shown to mediate adherence of H. pylori to human blood group antigens on gastric epithelial cells
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. However, the role of babA2 gene in the development of GC and PUD remains undefined. It is well established that differential cagA and vacA genetic characteristics exist in H. pylori strains isolated from different geographical regions. Therefore, using molecular techniques to study the association of H. pylori genotypes or strains with gastroduodenal diseases has become an important study area. The current study was done with an objective to identify the frequency cagA, cagA3 / region subtypes, babA2 and vacA genotypes of H. pylori isolates and their association with gastroduodenal diseases. H. pylori genotyping: DNA was isolated from the bacterial growth and H. pylori positive gastric tissues using the QIAamp DNA mini kit (QIAGEN, Hilden, Germany) as per the manufacturer's instruction and subjected to PCR for the presence of cagA. Further, the detection of cagA 3 / region subtypes, babA2 and vacA genotypes of H. pylori was carried out by PCR using specific primers (Table I) . PCR was performed in a 50 µl reaction volume containing 100 ng of genomic DNA, 1 X PCR buffer, 1.5 mM MgCl 2 , 0.2 mM each deoxynucleotide, 0.5 µM each specific primer and 1.25U of Taq DNA polymerase. PCR cycles for cagA and vacA genotypes were as follows: predenaturation at 94 The histopathological characteristics of the gastric mucosa in H. pylori positive patients in PUD and NUD are shown in Table II . As per our diagnostic criteria, / region was higher both in GC and PUD, the difference was not significant (Table V) . (Table III) . babA2 genotype was significantly associated with PUD (P=0.003) and not with GC (P=0.789) ( Table V) .
Material & Methods
Presence of vacA gene in our H. pylori isolates was 89.2 per cent (182/204) and the frequency in different groups was as follows: GC 94.3 (33/35), PUD 97.2 (35/36) and NUD 85.7 per cent (114/133). Mixed infection was detected in 3 (8.5%) and 5 (4.4%) patients with PUD and NUD, respectively. None of the patients with GC had mixed infection.
The overall distributions of different signal sequence alleles in our patient populations were as follows: s1a 126 (69%), s1b 2 (1.09%), s2 44 (24.17%), s1a/s1b 3 (1.6%), s1a/s2 3 (1.6%), s1a/s1b/s2 2 (1.09%) and untypeable 2 (1.09%). The distribution of signal sequence in different groups of patients was as follows: in GC (n=33)-s1a 28 (84.8%), s2 04 (12.1%), untypeable 01 (3%); in PUD (n=35)-s1a 27 (77.1%), s2 05 (14.3%), s1a/s1b 01 (2.9%), s1b/s2 01 (2.9%), s1a/ s1b/s2 01 (2.9%), and in NUD (n=114)-s1a 71 (62.3%), s1b 02 (1.8%) s2 35 (30.7%), s1a/s1b 02 (1.8%), s1a/ s2 02 (1.8%), s1a/s1b/s2 01 (0.9%), untypeable 01 (0.9%). Majority of isolates were either s1a or s2. Out of 126 s1a positive isolates, 107 (82.6%) were found to be cagA positive and out of 44 s2 positive isolates, 29 (65.9%) were positive for cagA.
Overall, the most prevalent genotype of vacA was s1a/m2 in our patients as compared to s1a/m1, s2/ m2 and s2/m1. Univariate logistic regression analysis showed that s1a allele was associated with gastric cancer (P=0.050) and s1a/m2 vacA genotype was associated with both gastric cancer (P=0.014) and PUD (P = 0.016) (Table VI) , while s2/m2 genotype was detected in significantly higher proportion from NUD.
Discussion
The presence of H. pylori in patients with GC in our study was low and had no association with GC. Other tissue based study from India also failed to show an association between H. pylori infection and GC
15
.
A high occurrence of cagA was seen in H. pylori isolates in the present study; 80 per cent in GC, 83.3 per cent in PUD 76.7 per cent in NUD. No correlation of cagA could be established with GC and PUD, although cagA had been identified as a virulence marker and associated with increased severity of disease in some geographic regions 16 . High prevalence of cagA (80-90%) independent of the disease status had been reported in other Indian studies as well 17, 18 . These studies indicate that cagA cannot be considered as the sole virulence marker for determination of the disease outcome at least in India as has been reported from other geographic regions 16 . It is possible that some other genes of cagA-PAI are responsible for pathogenicity and disease outcome. There is inconsistency in the prevalence and association of babA2 genotype with the gastric diseases. However we reported 31.4 per cent prevalence of babA2 in our population and found significant association with PUD when compared with NUD (P=0.003). Studies from China and four European countries reported the prevalence of babA2 25 and 30 -60 per cent, respectively and found no correlation with clinical disease 19, 20 . Recently, a study from Thailand reported 92 per cent positivity of babA2 gene and found no significant association with clinical outcome 21 . However, a significant association of babA2 genotype with duodenal ulcer (DU) and GC was observed in Brazil and Germany 22, 23 .
We showed that s1a allele had significant association with GC and it was more frequently present in patients with PUD. The prevalence of vacAs2 strain in our population was approximately 25 per cent, which is similar to our previous report of 27 per cent in children 24 , but is discordant with other Indian studies where the prevalence of vacAs2 strain ranged from 2 to 10 per cent 17, 25 . We also found very high number of cagA positive vacAs2 strain (65.9%) in our patient population. This is the first study that reports high prevalence of cagA positive in vacAs2 strains. These differences may be geographical and because of high frequency of cagA positive strains in our population with no significant difference between disease and control populations. Excluding the mixed infection and combining the groups, we observed that vacA s1a/m2 was frequently found in our study population, which is similar to several other findings 26 . Univariate regression analysis in our patients showed that s1a/m2 vacA genotype was associated with both gastric cancer (P=0.014) and PUD (P=0.016). These findings are markedly different from those reported association of s1a/m1 vacA genotype with PUD and GC 27, 28 .
In contrary to this, few studies had found no correlation of vacA genotypes with clinical outcome. However, Bulent et al found that the presence of vacA genotype was not a predictive marker for peptic ulcer and non-ulcer dyspepsia 28 .
In conclusion, H. pylori infection is strongly associated with PUD. cagA and cagA3 / region subtypes of H. pylori have no association with GC and PUD in the study. A significantly higher proportion of patients with GC have s1a allele and s1a/m2 vacA genotype. Besides s1a/m2 vacA genotype, babA2 is also associated with PUD. The study suggests that different virulence attributes of H. pylori are involved in differential outcome of gastric disorders.
